Genetic Vaccines and Therapy

unofficial impact factor 1.86

Open Access Highly Access

DNA vaccines: improving expression of antigens

Helen S Garmory*, Katherine A Brown and Richard W Titball

Genetic Vaccines and Therapy 2003, 1:2 doi:10.1186/1479-0556-1-2

Accesses  

  • Last 30 days: 253 accesses
  • Last year: 3718 accesses
  • All time: 38597 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access

Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen

Ekaterina Alekseeva, Irina Sominskaya, Dace Skrastina, Irina Egorova, Elizaveta Starodubova, Eriks Kushners, Marija Mihailova, Natalia Petrakova, Ruta Bruvere, Tatyana Kozlovskaya, Maria Isaguliants, Paul Pumpens Genetic Vaccines and Therapy 2009, 7:7 (8 June 2009)

Research article   Open Access

Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity

Matthias Tenbusch, Seraphin Kuate, Bettina Tippler, Nicole Gerlach, Simone Schimmer, Ulf Dittmer, Klaus Überla BMC Immunology 2008, 9:13 (11 April 2008)

Short paper   Open Access

Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation

Norma Perez, Pascal Bigey, Daniel Scherman, Olivier Danos, Marc Piechaczyk, Mireia Pelegrin Genetic Vaccines and Therapy 2004, 2:2 (23 March 2004)